Kyle Kazan of Glass House Brands calls for unity in California's cannabis market and shares optimism about federal reform at Benzinga event.

BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...

Biden’s DOJ also sued Tennessee because the state does not allow doctors to facilitate ... Trump signaled support for such actions earlier this year, saying: “I will sign a new executive ...

If all you want to do is link your ... Motley Fool Money does not cover all offers on the market. Motley Fool Money is 100% owned and operated by The Motley Fool. Our knowledgeable team of personal ...

A lot of emphasis was placed on new guardrails to ensure that DBG does not go down the bankrupting paths of the ... new bank ...

The smaller the standard deviation, the greater the agreement among analysts. While the consensus ... Are you wondering why? They usually do that to drum up interest in shares of companies that ...

Despite a recent 5% share price dip, Consolidated Edison’s Q3 earnings beat estimates, and it revised its 2024 EPS guidance ...

Both enjoy a populist pedigree, having risen to power amid a global tide of disillusionment with traditional forms of governance, Vincent Kyle Parada, a former defence analyst for the Philippine ...

These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

DONALD TRUMP TOLD THE COUNTRY WHAT HE WOULD DO AS PRESIDENT ... Republican political analyst Rob Gray and Democratic analyst Mary Anne Marsh go On The Record about their picks for the worst ...

Even with Nvidia Corp. shares up 200% this year, they continue to rack up big praise from analysts. Melius Research analyst Ben Reitzes compared the company’s positioning to that of Apple Inc ...